This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Beyond Air's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.022. Beyond Air's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.
As of today (2024-04-23), Beyond Air's share price is $1.21. Beyond Air's Median PS Value is $0.00. Therefore, Beyond Air's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Beyond Air's Median PS Value or its related term are showing as below:
XAIR's Price-to-Median-PS-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.77 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Beyond Air Median PS Value Historical Data
The historical data trend for Beyond Air's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Beyond Air's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beyond Air Price-to-Median-PS-Value Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Beyond Air's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Beyond Air's Price-to-Median-PS-Value falls into.
Beyond Air Median PS Value Calculation
Beyond Air's Median PS Value for today is calculated as
10-Year Median PS Ratio is 0.
Beyond Air's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.022.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beyond Air (NAS:XAIR) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Beyond Air's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
1.21
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beyond Air Median PS Value Related Terms
Thank you for viewing the detailed overview of Beyond Air's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XAIR has been successfully added to your 